Hesio (Diosmin, Hesperidin)

Hesio is indicated for several conditions that involve impaired venous return and capillary fragility.

• Chronic venous insufficiency, including leg heaviness, swelling, and aching.
• Symptomatic relief of hemorrhoidal disease such as bleeding and discomfort.
• Management of uncomplicated varicose veins to reduce pain and edema.
• Support of microcirculatory function after prolonged standing or sedentary periods.
• Adjunctive therapy for patients with mild to moderate peripheral venous disorders.

• Diosmin and hesperidin act synergistically to enhance venous tone by strengthening the smooth‑muscle layer of the vein wall and reducing venous capacitance. They increase the resistance of superficial veins, promote lymphatic drainage, and stabilize endothelial cells, which lowers capillary permeability. The flavonoids also exhibit anti‑inflammatory activity by inhibiting prostaglandin synthesis and free‑radical formation, contributing to reduced edema and tissue irritation.

Adverse reactions to Hesio are generally mild, but rare serious events have been reported.

Common

• Gastro‑intestinal discomfort such as nausea, abdominal pain or dyspepsia.
• Headache or mild dizziness.
• Transient skin flushing or warmth.

Serious

• Allergic reactions including rash, pruritus, or angio‑edema.
• Hepatic enzyme elevation indicating possible liver irritation.
• Severe hypotension or syncope in susceptible individuals.

When considering Hesio, certain precautions should be observed to ensure safe use in specific populations and clinical situations.

• Use with caution in patients with known hypersensitivity to flavonoids or any excipients.
• Assess liver function before initiating therapy, especially in individuals with pre‑existing hepatic disease.
• Monitor blood pressure in patients prone to hypotension or taking antihypertensive agents.
• Avoid use during pregnancy or lactation unless advised by a healthcare professional.
• Consider potential interactions with anticoagulant or antiplatelet therapy and adjust monitoring accordingly.
• Do not exceed the recommended daily dose without medical supervision.

Hesio may affect the activity of other medicines; awareness of possible interactions helps prevent adverse outcomes.

Avoid

• Concomitant use with potent anticoagulants (e.g., warfarin, direct oral anticoagulants) due to increased bleeding risk.
• Simultaneous administration of high‑dose aspirin or other non‑steroidal anti‑inflammatory drugs (NSAIDs) that may potentiate gastrointestinal irritation.

Use with caution

• Combination with antihypertensive agents, as additive blood‑pressure‑lowering effects may occur.
• Co‑administration with other flavonoid‑rich supplements, which could amplify pharmacodynamic actions.
• Use alongside drugs metabolized by CYP3A4, as hesperidin may modestly inhibit this pathway.
• Patients on diuretics should be observed for electrolyte shifts when adding Hesio.